Cardiovascular Disease

Cardiovascular Disease May Benefit From Chinese Medicine

Cardiovascular Disease May Benefit From Chinese Medicine

Herbal alternatives used in traditional Chinese medicine may help treat or prevent cardiovascular disease.

Cholesterol Significantly Reduced by Blocking Angiopoietin-like 3 Gene

Cholesterol Significantly Reduced by Blocking Angiopoietin-like 3 Gene

Two research groups successfully reduced cholesterol in humans to block the angiopoietin-like 3 gene.

Cardiovascular Disease Risk Reduced With Healthy Fats

Cardiovascular Disease Risk Reduced With Healthy Fats

Replacing saturated fats with polyunsaturated fats and monounsaturated fats can reduce cardiovascular disease risk.

Risk of Cardiovascular Disease High With 'Healthy' Obesity

Risk of Cardiovascular Disease High With 'Healthy' Obesity

People with metabolically healthy obesity still have a higher risk of cardiovascular disease.

Short Sleep Duration May Increase Risk for CVD Mortality

Short Sleep Duration May Increase Risk for CVD Mortality

By

Mortality risk is increased in association to short sleep duration in cardiovascular disease and stroke.

Assessing Mortality Risks in CVD, T2DM vs CKD

Assessing Mortality Risks in CVD, T2DM vs CKD

By

Chronic kidney increases the risk of mortality in patients with cardiovascular disease.

Sitagliptin Improves Triglycerides and Glucose Tolerance

Sitagliptin Improves Triglycerides and Glucose Tolerance

By

Sitagliptin improved several lipid parameters for men who were overweight and had prediabetes.

Dapagliflozin May Benefit Progression of Atherosclerosis

Dapagliflozin May Benefit Progression of Atherosclerosis

By

Dapagliflozin improved endothelial function in patients with type 2 diabetes.

Subclinical Myocardial Damage in Obesity May Be Mitigated by Physical Activity

Subclinical Myocardial Damage in Obesity May Be Mitigated by Physical Activity

By

Individuals who had the lowest levels of recommended physical activity had elevated levels of high-sensitivity cardiac troponin T.

Maternal and Fetal Risk with Anticoagulation in Pregnancy

Maternal and Fetal Risk with Anticoagulation in Pregnancy

Anticoagulation treatment for patients with mechanical heart valves during pregnancy is linked to maternal and fetal risks.

Long-Term Outcomes of Evacetrapib on Cardiovascular Outcomes

Long-Term Outcomes of Evacetrapib on Cardiovascular Outcomes

Evacetrapib does not affect the primary efficacy end point of first occurrence of any component of a composite of death from cardiovascular causes in patients with high-risk vascular disease.

Cardiovascular Predictions in Liver Transplant Candidates

Cardiovascular Predictions in Liver Transplant Candidates

By

Stress microvascular perfusion assessments were found to be highly predictive of cardiovascular outcomes in liver transplant candidates.

Cardiovascular Disease Mortality Risk Reduced With Significantly Lower Blood Pressure Targets

Cardiovascular Disease Mortality Risk Reduced With Significantly Lower Blood Pressure Targets

By

Significantly lower blood pressure can reduce cardiovascular disease mortality risk.

Childhood Cardiovascular Risk Factors Linked to Midlife Cognitive Performance

Childhood Cardiovascular Risk Factors Linked to Midlife Cognitive Performance

By

The cardiovascular risk factors of high systolic blood pressure, high serum total cholesterol, and smoking were independently associated with worse cognitive performance in midlife.

Impaired Coronary Distensibility Index Linked to Adverse Childhood Experience, Increases MACE Risk

Impaired Coronary Distensibility Index Linked to Adverse Childhood Experience, Increases MACE Risk

By

Individuals with adverse childhood experience may be at greater risk for major adverse cardiovascular events.

Glucagon-Like Peptide-1 Receptor Agonists May Lower Cardiovascular Risk in Type 2 Diabetes

Glucagon-Like Peptide-1 Receptor Agonists May Lower Cardiovascular Risk in Type 2 Diabetes

By

Glucagon-like peptide-1 receptor agonist therapy was associated with lower risk for acute MI, stroke, and all-cause mortality.

Does Monthly, High-Dose Vitamin D Supplementation Prevent CVD?

Does Monthly, High-Dose Vitamin D Supplementation Prevent CVD?

By

A randomized double-blind placebo-controlled trial examined the relationship between high-dose oral vitamin D supplementation and reduced risk of cardiovascular disease.

Frequent Hot Flashes Give Cardiovascular Insight In Young Women

Frequent Hot Flashes Give Cardiovascular Insight In Young Women

By

Frequent hot flashes in younger women were linked to endothelial function, providing more insight into the cardiovascular disease risk status of patients.

Targeted Approach Needed for Cholesterol Screenings

Targeted Approach Needed for Cholesterol Screenings

Study shows prevalence of atherosclerotic cardiovascular disease risk among adults under 50 without diabetes is low.

Low Systolic Blood Pressure Target May Increase Cardiovascular Risks

Low Systolic Blood Pressure Target May Increase Cardiovascular Risks

By

Achieving a systolic blood pressure goal of <120 mm Hg may have adverse cardiovascular effects for some patients.

Cardiovascular Disease: A Major Global Burden

Cardiovascular Disease: A Major Global Burden

Researchers find that cardiovascular disease is a major global burden despite declines in mortality rates.

Cardiovascular and Mortality Risk Reduction in Type 1 Diabetes

Cardiovascular and Mortality Risk Reduction in Type 1 Diabetes

By

There was a steep graded association between controlled cardiovascular risk factors and outcomes in patients with type 1 diabetes.

Hypertension, High Cholesterol Risks Similar for 'Social Smokers'

Hypertension, High Cholesterol Risks Similar for 'Social Smokers'

Social smokers have the same risk level for hypertension and elevated cholesterol as regular smokers.

Achieving Optimal Cardiovascular Health by Middle Age Adds Years to Life

Achieving Optimal Cardiovascular Health by Middle Age Adds Years to Life

People with optimal cardiovascular health in middle age live an average of 4 years longer than others.

Cardiovascular Risks Not Increased With Long-Acting Beta2-Agonist for COPD

Cardiovascular Risks Not Increased With Long-Acting Beta2-Agonist for COPD

By

Combination therapy with an inhaled long-acting beta2-agonist and an inhaled corticosteroid did not affect all-cause mortality compared with inhaled placebo.

Cardiovascular Events in Hypogonadism May Be Reduced With Testosterone Therapy

Cardiovascular Events in Hypogonadism May Be Reduced With Testosterone Therapy

By

Testosterone replacement therapy may show a protective effect against myocardial infarction and stroke in men with secondary hypogonadism.

CVD and Mortality Risk Reduced with Cycle Commuting

CVD and Mortality Risk Reduced with Cycle Commuting

Over 5 years, cyclists' risks of cardiovascular disease and mortality were significantly decreased.

Does Moderate Alcohol Consumption Have a Role in Cardiovascular Disease Prevention?

Does Moderate Alcohol Consumption Have a Role in Cardiovascular Disease Prevention?

By

The effects of alcohol consumption on cardiovascular disease were explored in a population-based study.

Long-term Cardiovascular Risk of Undiagnosed Chest Pain

Long-term Cardiovascular Risk of Undiagnosed Chest Pain

By

Patients with undiagnosed chest pain in primary care rarely undergo diagnostic testing, but experience an increased risk of both fatal and non-fatal CV events.

Role of Race and Ethnicity in Cardiovascular Health

Role of Race and Ethnicity in Cardiovascular Health

By

Experts weigh in on how to improve racial and ethnic disparities in cardiovascular health.

Sign Up for Free e-Newsletters